Heart drug intended for blacks stirs ethical controversy

11/1/2004 | Star Tribune (Minneapolis-St. Paul, Minn.)

The BiDil pill, which combines two drugs to treat a type of heart failure, reportedly with greater success among blacks than whites, has become controversial as ethicists debate the issue. Some say there is no evidence blacks fare better with treatment than whites, as researchers plan to reveal next week the results of a major trial involving only black participants.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY